Sort   by:  
 Page size 
UnknownQuantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.
Not available
S-EPMC5519491 | biostudies-literature
UnknownRisk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis.
Not available
S-EPMC4946794 | biostudies-literature
UnknownA Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis.
Not available
S-EPMC7239345 | biostudies-literature
UnknownAssociation of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.
Not available
S-EPMC7495329 | biostudies-literature
TranscriptomicsRNA-sequencing of the small-RNA transcriptome in blood, across three time-points in severe psoriasis patients treated with the tumor necrosis factor (TNF) inhibitor, etanercept
Blood (mRNA and miRNA) and skin mRNA transcriptomes were investigated across three time-points in a pilot investigation of ten severe psoriasis patients, treated with the tumor necrosis factor (TNF) inhibitor, etanercept. We used illumina RNA-sequencing to analyse the small-RNA transcriptome in bloo...
ORGANISM(S): Homo sapiens 
2018-09-21 | E-MTAB-6428 | biostudies-arrayexpress
TranscriptomicsRNA-sequencing of the mRNA transcriptome in lesional and non-lesional skin, across three time-points in severe psoriasis patients treated with the tumor necrosis factor (TNF) inhibitor, etanercept
Blood (mRNA and miRNA) and skin mRNA transcriptomes were investigated across three time-points in a pilot investigation of ten severe psoriasis patients, treated with the tumor necrosis factor (TNF) inhibitor, etanercept. We used illumina RNA-sequencing to analyse the small-RNA transcriptome in bloo...
ORGANISM(S): Homo sapiens 
2018-09-21 | E-MTAB-6556 | biostudies-arrayexpress
TranscriptomicsRNA-sequencing of the mRNA transcriptome in blood, across three time-points in severe psoriasis patients treated with the tumor necrosis factor (TNF) inhibitor, etanercept
Blood (mRNA and miRNA) and skin mRNA transcriptomes were investigated across three time-points in a pilot investigation of ten severe psoriasis patients, treated with the tumor necrosis factor (TNF) inhibitor, etanercept. We used illumina RNA-sequencing to analyse the mRNA transcriptome in blood
ORGANISM(S): Homo sapiens 
2018-10-01 | E-MTAB-6555 | biostudies-arrayexpress
UnknownAnakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT).
Not available
S-EPMC9255857 | biostudies-literature
UnknownLoss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease.
Not available
S-EPMC7477255 | biostudies-literature
Sort   by:  
 Page size